Placebo-responsive Parkinson patients sho... - Cure Parkinson's

Cure Parkinson's

25,681 members27,014 posts

Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus

Farooqji profile image
2 Replies

nature.com/articles/nn1250

Full article

drive.google.com/file/d/1N3...

Written by
Farooqji profile image
Farooqji
To view profiles and participate in discussions please or .
2 Replies
Boscoejean profile image
Boscoejean

Information is not very readily available

Boscoejean profile image
Boscoejean

Is this the gist of this information:

semanticscholar.org/paper/T...

"What is the role of placebo in neurotherapeutics?

E. Frisaldi, A. Shaibani, M. Trucco, Edoardo Milano, F. Benedetti

Psychology, Medicine

Expert review of neurotherapeutics

2021

TLDR

The biological mechanisms and the clinical implications of placebo effects with particular emphasis on neurology and psychiatry, for example in pain, movement disorders, depression, are described.

Abstract

ABSTRACT Introduction The widespread use of the word ‘placebo’ in the medical literature emphasizes the importance of this phenomenon in modern biomedical sciences. Neuroscientific research over the past thirty years shows that placebo effects are genuine psychobiological events attributable to the overall therapeutic context, and can be robust in both laboratory and clinical settings. Areas covered Here the authors describe the biological mechanisms and the clinical implications of placebo effects with particular emphasis on neurology and psychiatry, for example in pain, movement disorders, depression. In these conditions, a number of endogenous systems have been identified, such as endogenous opioids, endocannabinoids, and dopamine, which contribute to the placebo-induced benefit. Expert opinion Every effort should be made to maximize the placebo effect and reduce its evil twin, the nocebo effect, in medical practice. This does not require the administration of a placebo, but rather the enhancement of the effects of pharmacological and nonpharmacological treatments through a good doctor–patient interaction. "

You may also like...

Can We Delay the Progression of the Signs of Parkinson's Disease? The Dose-Response SPARX3 Trial

https://www.newswise.com/articles/research-highlights-from-2021-acsm-virtual-annual-meeting-exercise

Parkinson's patient experiences improvements following stem cell infusions

in Sugarland, TX https://www.frontiersin.org/articles/10.3389/fneur.2023.1257080/full......

Why should I take extra vitamins

doing. https://blog.designsforhealth.com/node/1001...

🧠 Methylation Regulates Alpha-Synuclein Expression and Is Decreased in Parkinson's Disease Patients' Brains

higher methylation potential (SAM/SAH ratio). https://pubmed.ncbi.nlm.nih.gov/19679632/ The ratio

37 articles on various neuroprotective agents

37 articles on various neuroprotective agents:...